Endocarditis prophylaxis revisited: Experimental evidence of efficacy and new Swiss recommendations

Schweizerische Medizinische Wochenschrift

Volumn 130, Issue 27-28, 2000, Pages 1013-1026

  Moreillon, P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Infectious endocarditis; Prophylaxis; Recommendations; Switzerland

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CEFUROXIME AXETIL; CLARITHROMYCIN; CLINDAMYCIN; TEICOPLANIN; VANCOMYCIN;

BACTEREMIA; BACTERIAL ENDOCARDITIS; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; REVIEW; RISK BENEFIT ANALYSIS; SWITZERLAND;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; ENDOCARDITIS; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HUMANS; MITRAL VALVE PROLAPSE; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS; SWITZERLAND;

EID: 0034636757     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Contrepois A. Notes on the early history of infective endocarditis and the development of an experimental model. Clin Infect Dis 1995;20:461-6.
2. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke endocarditis service. Am J Med 1994;96:200-9.
3. Berlin JA, Abrutyn E, Strom BL, Levison ME, Korzeniowski OM, Feldman RS, et al. Incidence of infective endocarditis in the Delaware valley, 1988-1990. Am J Cardiol 1995; 76:953-6.
4. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine 1995;74: 324-39.
5. Benn M, Hagelskjaer LH, Tvede M. Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. J Intern Med 1997;242:15-22.
6. McKinsey DS, Ratts TE, Bisno AI. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med 1987;82:681-8.
7. Schweizerische Arbeitsgruppe für Endokarditisprophylaxe. Prophylaxe der bakteriellen Endokarditis. Schweiz Med Wochenschr 1984;114:1246-52.
8. Schweizerische Arbeitsgruppe für Prophylaxe der bakteriellen Endokarditis. Schweiz Ärztezeitung 1986;67:348-53.
9. Leport C, Horstkotte D, Burckhardt D. Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Group of experts of the International Society for Chemotherapy. Eur Heart J 1995;16(Suppl B):126-31.
10. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis, recommendations by the American Heart Association. JAMA 1997;277:1794-801.
11. Gould K, Ramirex-Ronda CH, Holmes RK, Sanford JP. Adherence of bacteria to heart valves in vitro. J Clin Invest 1975;56:1364-70.
12. Baddour LM. Virulence factors among gram-positive bacteria in experimental endocarditis. Infect Immun 1994;62: 2143-8.
13. Crawford J, Russell C. Comparative adhesion of seven species of streptococci isolated from the blood of patients with sub-acute bacterial endocarditis to fibrin-platelet clots in vitro. J Appl Bact 1986;60:127-33.
14. Moreillon P, Overholser CD, Malinverni R, Bille J, Glauser MP. Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal disease. J Infect Dis 1988;157:990-5.
15. Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, François P, et al. Rote of Staphylococcus aureus coagulase and clumping factor in the pathogenesis of experimental endocarditis. Infect Immun 1995;63:4738-43.
16. Hall G, Hedstrom SA, Heimdahl A, Nord CE. Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin Infect Dis 1993;17:188-94.
17. Hall G, Heimdahl A, Nord CE. Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction. Eur J Clin Microbiol Dis 1996;15:646-9.
18. van der Meer JT, van Wijk W, Thompson J, Vandenbroucke JP, Valkenburg HA, Michel MF. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 1992;339:135-9.
19. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995;332:38-44.
20. Glauser MP, Bernard JP, Moreillon P, Francioli P. Successful single-dose amoxicillin prophylaxis against experimental endocarditis: evidence for two mechanisms of protection. J Infect Dis 1983;147:568-75.
21. Moreillon P, Francioli P, Overholser D, Meylan P, Glauser MP. Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius. J Infect Dis 1986;154:801-7.
22. Malinverni R, Overholser CD, Bille J, Glauser MP. Antibiotic prophylaxis of experimental endocarditis after dental extraction. Circulation 1988;77:182-7.
23. Durack DT, Petersdorf RG. Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest 1973;52: 592-8.
24. Glauser MP, Francioli P. Successful prophylaxis against experimental streptococcal endocarditis with bacreriostatic antibiotics. J Infect Dis 1982;146:806-10.
25. Fluckiger U, Francioli P, Blaser J, Glauser MP, Moreillon P. Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci. J Infect Dis 1994;169:1397-400.
26. Fluckiger U, Moreillon P, Blaser J, Bickle M, Glauser MP, Francioli P. Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrob Agents Chemother 1994;38:2846-9.
27. Dankert J, Van den Werff J, Zaat SAJ, Joldersma W, Klein D, Hess J. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun 1995;63:663-71.
28. Berney P, Francioli F. Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J Infect Dis 1990; 161 : 281-5.
29. Karchmer AW. Infective endocarditis. In: Braunwald E, ed. Heart Disease. A textbook for cardiovascular medicine. 5th edition. Philadelphia: Saunders; 1997. p. 1077.
30. Corone P, Lévy A, Hallali P, Davido A, Wyler Y, Corone A. A propos de 54 cas d'endocardites observées en 32 ans sur une population de 2038 cardiopathies congénitales. Arch Mal Cœur 1989;82:779-84.
31. Morris CD, Reller MD, Menashe VD. Thirty-year incidence of infective endocarditis after surgery for congenital heart detect. JAMA 1998;279:599-603.
32. Perloff JK, Child JS. Congenital Heart Disease in Adults. 4th edition. Philadelphia: Saunders: 1994.
33. Markiewicz W, Stoner J, London E, Hunt SA, Popp RL. Mitral valve prolapse in one hundred presumably healthy young females. Circulation 1976;53:464-73.
34. Nishimura RA, McGoon MD, Shub C, Miller FA, Ilstrup DM, Tajik AJ. Echocardiography documented mitral-valve prolapse. Long-term follow-up of 237 patients. N Engl J Med 1985;313:1305-9.
35. MacMahon SW, Mickey AJ, Wilcken DEL, Wittes JT, Feneley MP, Hickie JB. Risk of infective endocarditis in mitral valve prolapse with and without precordial systolic murmurs. Am J Cardiol 1986;58:105-8.
36. Marks AR, Choong CY, Sanfilippo AJ, Rerré M, Weyman AE. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med 1989; 320:1031-6.
37. Kim S, Kuroda T, Nishinaga M, Yamasawa M, Watanabe S, Mitsuhashi T, et al. Relation between severity of mitral valve regurgitation and prognosis of mitral valve prolapse: echocardiographic follow-up study. Am Heart J 1996; 132: 348-55.
38. Friedlander AH, Marshall CE. Pathogenesis and prevention of native valve infective endocarditis in elderly dental patients. Drugs Aging 1994;4:325-30.
39. Pulvirenti JJ, Kerns E, Benson C, Lisowski J, Demarais P, Weinstein RA. Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression. Clin Infect Dis 1996; 22:40-5.
40. Rahn R, Schneider S, Diehl O, Schafer V, Shah PM. Preventing post-treatment bacteremia: comparing topical povidoneiodine and chlorhexidine. J Am Dent Assoc 1995;126: 1145-9.
41. Carrel JP, Gebran G, Samson J. Endocardites infectieuses et antibioprophylaxie lors de traitements dentaires. Rev Med Suisse Romande 1998;18:37-45.
42. Woodman AJ, Vidic J, Newman HN, Marsh PD. Effect of repeated high-dose prophylaxis with amoxycillin on the resident oral flora of adult volunteers. J Med Microbiol 1985;19:15-23.
43. Snady H, Korsten MA, Way JD. The relationship of bacteremia to the length of injection needle in endoscopic variceal sclerotherapy. Gastrointest Endosc 1985;31:243-6.
44. Dajani AS, Bawdon RE, Berry MC. Oral amoxicillin as prophylaxis for endocarditis: what is the optimal dose. Clin Infect Dis 1994;18:157-60.
45. Vermot D, Entenza JM, Vouillamoz J, Glauser MP, Moreillon P. Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. Antimicrob Agents Chemother 1996;40:809-11.
46. Rouse MS, Steckelberg JM, Brandt CM, Patel R, Miro JM, Wilson WR. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. Antimicrob Agents Chemother 1997;41: 1673-6.
47. Ginsburg CM, McCracken GH Jr, Petruska M, Olsen K. Pharmacokinetics and bactericidal activity of cefuroxime axetil. Antimicrob Agents Chemother 1985;28:504-7.
48. Iravavni A, Richard GA. Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections. Antimicrob Agents Chemother 1989;33: 1212-6.
49. Fluckiger U, Bickle M, Blaser J, Francioli P, Glauser MP. Prevention of streptococcal endocarditis in rats using simulated human serum profiles of amoxicillin and cefuroxime axetil. In Program and Abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. ASM 1991. Chicago, II., Abstract # 359.
50. Entenza JM, Calandra T, Moosmann Y, Malinverni R, Glauser MP. Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats. Antimicrob Agents Chemother 1992;36:1256-62.
51. Wilson APR, Gruenenberg RN. Use of teicoplanin in community medicine. Eur J Clin Microbiol Infect Dis 1994; 38:701-10.
52. Kearney RA, Eisen HJ, Wolf JE. Nonvalvular infections of the cardiovascular system. Ann Intern Med 1994;121:219-30.
53. Pearson ML. Guidelines for prevention of intravascular device-related infections. Am J Infect Control 1996;24:262-93.
54. Jones L, Braithwaite BD, Davies B, Heather BP, Earnshaw JJ. Mechanism of late prosthetic vascular graft infection. Cardiovasc Surg 1997;5:486-9.
55. Bayliss R, Clark C, Oackley CM, Somerville W. The teeth and infective endocarditis. Br Heart J 1983;50:506-12.
56. van der Meer JT, Thompson J, Valkenburg HA, Michel ME Epidemiology of bacterial endocarditis in the Netherlands. I. Patient characteristics. Arch Intern Med 1992; 152: 1863-8.
57. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in the Netherlands. II. Antecedent procedures and use of prophylaxis. Arch Intern Med 1992;152:1869-73.
58. Durack DT, Kaplan EL, Bisno AL. Apparent failures of endocarditis prophylaxis. Analysis of 53 cases submitted to a national registry. JAMA 1983;250:2318-22.
59. Horstkotte D, Friedrichs W, Pippert H, Bricks W, Loogen F. Nutzen der Endokarditisprophylaxe bei Patienten mit prosthetischen Herzklappen. Z Kardio 1986;75:8-11.
60. Lacassin F, Hoen B, Leport C, Selton-Suty C, Delahaye F, Goulet V, et al. Procedures associated with infective endocarditis in adults. A case control study. Eur Heart J 1995; 16:1968-74.
61. Imperiale TF, Horwitz RI. Does prophylaxis prevent post-dental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 1990;88:131-6.
62. Srom LB, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, et al. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med 1998;129:761-9.
63. Clemens JD, Ransohoff F. A quantitative assessment of pre-dental antibiotic prophylaxis for patients with mitral-valve prolapse. J Chron Dis 1984;37:531-44.
64. Bor DH, Himmelstein DU. Endocarditis prophylaxis for patients with mitral valve prolapse. A quantitative analysis. Am J Med 1984;76:711-7.
65. Durack DT. Antibiotics for prevention of endocarditis during dentistry: time to scale back? Ann Intern Med 1998;129: 829-31.
66. Li W, Somerville J. Infective endocarditis in the grown-up congenital heart (GUCH) population. Eur Heart J 1998; 19: 166-73.